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Synthesis, characterization and in vitro antiproliferative and antibacterial 
studies of tetraazamacrocyclic complexes of Co(II) and Cu(II) with 
pyromellitic acid
MIRJANA ANTONIJEVIĆ NIKOLIĆ*†, JELENA ANTIĆ STANKOVIĆ‡ and SLAĐANA B. TANASKOVIĆ‡
†Higher Medical and Business-technological School of Applied Studies, Hajduk Veljkova 10, 15000 Šabac, Serbia
‡Faculty of Pharmacy, Vojvode Stepe 450, 11000 Belgrade, Serbia
New cationic tetranuclear Co(II) and neutral binuclear Cu(II) complexes with tpmc 
(N,N´,N´´,N´´´-tetrakis-(2-pyridylmethyl)-1,4,8,11-tetraazacyclotetradecane) and bridging 
pyromellitate ligand pma (tetraanion 1,2,4,5-benzenetetracarboxylic acid) were isolated. The 
composition of the compounds is proposed based on elemental analyses (C, H, N, M = Cu, Co), 
molar conductivity determination, UV-vis, FTIR, EPR, LC-MS and reflectance spectroscopy, 
magnetic measurements, cyclic voltammetry, as well as TG and DTA. It is proposed that in 
[Co4(pma)(tpmc)2](ClO4)4·6H2O (1), cobalt(II) is six-coordinate out of cyclam rings and one 
OCO- from pma participates in coordination with one Co(II). In the case of 
[Cu2(pma)tpmc]∙8H2O (2), one OCO- from pma bridges two Cu(II). The cytotoxic activity of 1 
and 2 was tested against tumor cell lines human cervix adenocarcinoma (HeLa), estrogen-
receptor-positive human breast cancer (MCF-7), human myelogenous leukemia (K562) and the 
human Caucasian Burkitt’s lymphoma (Ramos). The IC50 values for 1 and 2 were within the 
range 44.66±2.39 to 152.40±2.28 μM, and from 140.88±3.51 to 192.05±2.09 μM, respectively. 
Both 1 and 2 were tested for antimicrobial activity. We determined that minimal inhibitory 
concentration for 1 against Staphylococcus aureus, Bacillus subtilis and Klebsiella pneumoniae 
was 25 mM. Complex 2 did not express activity against tested microbial strains.
Keywords: Co(II) and Cu(II) Complexes; tpmc; Pyromellitate ligand; Antimicrobial activity; 
Cytotoxic activity
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21. Introduction
Tetraazamacrocyclic ligands and their metal complexes are very attractive compounds and have 
been intensively studied over the last decades because of their interesting structure, redox 
properties, possible applications as catalysts, new magnetic materials, ion selective 
potentiometric sensors, agents for nucleic acid cleavage, etc. [1-4]. Their potential application as 
antitumor [5], antiviral (including HIV activity) [6-7], antibacterial, antifungal or antimalarial 
agents have been examined [8-12].
Tetraazamacrocyclic ligand with four pendant arms, N,N',N'',N'''-tetrakis(2-
pyridylmethyl)-1,4,8,11-tetraazacyclotetradecane (tpmc), forms mono-, bi- or tetranuclear 
complexes having various structures depending on the metal center and the number of 
co-ligands. Metal centers are coordinated with tpmc in exo or endo mode. In bi- and tetranuclear 
complexes, depending on the number, type and size of donor atoms of additional ligands, metal 
centers, as well as the reaction conditions, different modes of macrocyclic conformations were 
found. Macrocyclic ligand adopts boat conformation when the additional ligand is bonded in a 
bridged or a combined chelate-bridged manner and a chair conformation when two other ligands 
are independently bonded in trans position. Metal centers are also bridged with N-(CH2)3-N 
fragments of the macrocyclic ring. Many macrocyclic mixed ligand Cu(II) and Co(II) complexes 
were previously described [13-19].
Polycarboxylates are used for the synthesis of hybrid materials, as multidonors, forming 
several possible coordination modes (monodentate, bis-monodentate, bidentate, tridentate) of the 
independent carboxylate groups [20-24]. Aromatic tetracarboxylic derivatives such as 1,2,4,5-
benzentetracarboxylic acid (H4pma, commonly known as pyromellitic acid) belong to important 
O-donor ligands which have been used to prepare metal-organic hybrid compounds [25]. It 
consists of a rigid planar C10 backbone due to the ð-bonding of the benzene ring and four freely 
rotating and flexible carboxylate groups. It can be deprotonated to give four available charges. 
Compounds with anion of a single negative charge are less common. The known compounds 
have dimeric units bridged by either H2pm2- or pm4-, a one-dimensional chain structure with 
bridging pm4-, a square grid of two-dimensional layers with bridging pm4-, and three-dimensional 
architectures with bridging pm4- [25b-f]. In some cases the structures have cavities and channels 
which are filled with water. Pyromellitic acid is an important raw material for the plastics 
industry due to its excellent thermal and mechanical properties.
3Copper, as a biologically important metal, plays an important role in endogenous 
processes like oxidative DNA-damage associated with aging and cancer. Many studies have 
focused on binuclear copper complexes due to their presence in metalloproteinase as well as their 
affinity for DNA [26-28].
In order to get better insight into the coordination chemistry of pyromellitate-containing 
cobalt(II) and copper(II) complexes, we have prepared two new analogous macrocyclic 
complexes of Co(II) and Cu(II) with tetracarboxylate ligand (pyromellitic acid). Their synthesis, 
physical and chemical properties, antimicrobial and cytotoxic potentials are reported in this 
paper.
2. Experimental
2.1. Preparation
Caution! Metal-organic perchlorate salts must be handled with caution! Use only the absolute 
minimum of material required!
Ligand tpmc was prepared and purified according to a procedure reported [29]. All other 
chemicals of p.a. grade are used as supplied, with the exception of CH3CN used for electrical 
conductivity measurements, recording electronic and LC/MS spectra, which was of HPLC grade 
purity.
2.2.1. [Co4(pma)(tpmc)2](ClO4)4·6H2O (1). The complex was prepared by adding aqueous 
solution of pyromellitic acid to a suspension of 188.3 mg (0.515 mmol) Co(ClO4)2·6H2O and 
145.5 mg (0.258 mmol) tpmc in 20 mL CH3CN. The amounts correspond to the mole ratio of the 
components of 4:2:1.5, respectively. The pH of the aqueous solution (15 mL) of pyromellitic 
acid (50.5 mg, 0.197 mmol) was adjusted to 5.5 by the dropwise addition of aqueous solution of 
0.1 M NaOH. The solution of pyromellitic acid was added carefully to a suspension of 
Co(ClO4)2·6H2O and tpmc with stirring. The mixture was stirred and refluxed at 80 C on a 
water bath for 3 h. The purple solution was concentrated to ½ of the starting volume and cooled 
in a refrigerator. After a few days the purple microcrystals were filtered and recrystallized from 
CH3CN-H2O (10:1, v/v). The compound was dried at room temperature. Yield 81%, FW = 
2121.39. Anal. Calcd. for Co4C78H102N16O30Cl4 (%): C, 44.16; H, 4.85; N, 10.56; Co, 11.10. 
Found: C, 44.54; H, 4.93; N, 10.62; Co, 10.73. It was (T = 20±2 °C) well soluble in CH3CN, 
4DMSO and DMF, insoluble in CH3OH, EtOH, (CH3)2CO and H2O; eff (room T) = 
4.96 BM/Co(II); M = 636 S cm2 mol-1. FTIR (KBr): v = 3441, 1610, 1104, 625, 1546, 1400, 
481, 419 cm-1; UV-vis (CH3CN): λmax = 527 nm (ε = 264 M-1cm-1); MS (LC-MS, 4000 V), 
(positive): m/z (%) 667.9 (7.83), 565.7 (3.01), 565.4 (7.83), 333.2 (16.27), 284.2 (39.16), 227.0 
(7.23), 189.1 (3.01).
2.2.2. [Cu2(pma)tpmc]∙8H2O (2). 2 was obtained by the reaction of Cu(NO3)2.3H2O (100 mg, 
0.414 mmol), tpmc (116.9 mg, 0.206 mmol) and pyromellitic acid (78.9 mg, 0.310 mmol) 
(neutralized previously to pH 6.0 with NaOH) (molar ratio 2:1:1.5) in CH3OH-H2O (1:1; v/v). 
Mixture was stirred and refluxed (~80 C) 3 h, concentrated to ½ of the initial volume and left in 
the refrigerator overnight. Microcrystalline blue product was separated by suction, dried, 
powdered, washed with ethanol, cold water and dried at room temperature. Yield 79%, FW = 
1086.04. Anal. Calcd. for C44H74O22N8Cu2 (%): C, 48.66; H, 5.75; N, 10.32; Cu, 11.69. Found: 
C, 48.30; H, 5.43; N, 9.99; Cu, 11.39. Product was insoluble in common solvents (H2O, CH3OH, 
EtOH, CH3CN, DMF, (CH3)2CO) except limited in DMSO. eff (room T) = 2.07 BM/Cu (II); 
FTIR (KBr): v = 3452, 1609, 1572, 1381, 469, 429 cm-1; Reflectance spectrum λmax = 654 nm. 
By heating microcrystals, its color changes at ~110 C turquoise, above ~190 C deep green, and 
from 210-250 C became brown, suggesting liberation of lattice water and some decomposition 
of the ligand(s) and/or complex.
2.2. Measurements
Elemental analyses were performed by standard methods in the Center for Instrumental Analyses 
ICTM in Belgrade. The Cu and Co contents were determined by using an atomic absorption 
spectrophotometer PERKIN-ELMER AAS-5100/PC. Electronic absorption spectrum of 1 in 
CH3CN (1×10-3 M) was recorded on a GBC UV-VIS Cintra 20 spectrophotometer. Reflectance 
spectrum of 2 was recorded on a CARY 17D spectrophotometer using MgO as standard. The 
correction for the position of broad maxima were performed by a computer using Kubelka-
Munks’ function. Magnetic susceptibility measurements were made at room temperature 
(20±2 °C) using an MSB-MKI balance (Sherwood Scientific Ltd., England). Data were corrected 
for diamagnetic susceptibilities using Pascal’s constants [30]. FTIR spectra (KBr disc technique) 
were recorded using a Perkin-Elmer FTIR 31725X spectrophotometer from 400-4000 cm-1. 
5Molar electrical conductivity in CH3CN for 1 (1×10-3 M) was measured at room temperature on 
a Hanna instruments HI 8820N conductometer. LC/MS (4000 V) spectrum for 1 was carried out 
on MS system consisting of 6210 (Time-of-Flight) (G1969 A, Agilent Technologies) in CH3CN 
(~1 mg of the sample/mL) in positive ion mode in the range 100-2000 m/z. Mobile phase was 
0.2% solution of HCOOH in the mixture of CH3CN-H2O (50:50; v/v). For the collection and 
processing of the results Mass-Hunter Workstation software was used. The most intense peak at 
~282 m/z originated from solvent system. MS peaks were measured up to 700 m/z. The 
simultaneous TG-DTA experiments were carried out using a SDT 2960 thermal analyzer in air 
(flow rate = 90 mL/min) from 20 to 580 C (heating rate = 15 C/min) using platinum cups. EPR 
spectrum of powdered sample was recorded at room temperature and 77 K on a Bruker 
ELEXSYS E 500 CW-EPR spectrometer operating at X-band frequency and equipped with an 
ER 036TM NMR Teslameter and E 41 FC frequency counter.
Electrochemical measurements for 2 were performed by METHROME 797 VC 
Compurtrace in a standard three-electrode cell: Pt disc as working, standard AgCl/Ag as 
reference and Pt as auxiliary electrodes. Measurements were carried out in 10 mL of DMSO. 
Concentration of the complex was about 1×10-4 M. CV was performed with the sweep rate of 50, 
100 and 200 mV/s, respectively, with the potential ranged from -1 V to 1 V versus AgCl/Ag, at 
room temperature (20±2 C). Oxygen was removed from the system by continuous bubbling 
with oxygen free N2.
2.3. In vitro evaluation of antiproliferative and antimicrobial activity
2.3.1. Antiproliferative activity. Stock solutions (10 µM) of 1 and 2 were made in DMSO, 
filtered through Millipore filters (0.22 μm), and diluted to the relevant working concentrations 
for use in the nutrient medium. The nutrient medium was RPMI 1640 for all cells without phenol 
red, supplemented with L-glutamine (3 mM), streptomycin (100 µg/mL), and penicillin 
(100 IU/mL), fetal bovine serum (10%; FBS; 56 °C heat-inactivated) and HEPES (25 mM), 
adjusted to pH 7.2 (bicarbonate solution). RPMI-1640, FBS, Hepes and L-glutamine were 
products of Sigma Chemical Co., St. Louis, MO, USA.
The human cervix adenocarcinoma (HeLa) and estrogen-receptor-positive human breast 
cancer (MCF-7) cells were cultured as monolayers in the nutrient medium (see above), while the 
human myelogenous leukemia (K562) and the human Caucasian Burkitt’s lymphoma (Ramos) 
6cells were maintained as suspension cultures in the same nutrient medium. All these cells were 
grown at 37 °C in 5% CO2 and a humidified air atmosphere.
The metabolic activity was assessed by using the CellTiter 96H Aqueous One Solution 
Cell Proliferation Assay (Promega, Madison/WI, USA), in accord with the manufacturer’s 
instructions.
The HeLa and MCF-7 cells were seeded (5×104/mL) into 96-well microtiter plates and 
20 h later, after cell adherence, five different concentrations of the test compounds were added to 
the wells. The final test compound concentrations were in the range of 12.5 μM to 200 μM. In 
addition, we tested the activity of the starting compounds (tpmc and pma) in the same 
concentration range. Only the nutrient medium was added to the cells in the control wells. 
Cisplatin was used as a positive control. For the K562 and Ramos cells the test compounds were 
added to cell suspensions (5×104/mL) 2 h after cell seeding, to the same final concentrations 
applied to the HeLa and MCF-7 cells. All experiments were carried out in triplicate. Nutrient 
medium with the corresponding concentrations of the test compounds, but without cells, was 
used as the blank probe [31]. 
After 48 h, 100 μL of cell suspension was incubated with 10 μL of the supplied MTS 
tetrazolium compound. After 3 h of incubation under standard conditions, the absorbance was 
measured at 492 nm by using an automated microplate reader Tecan Safire (Tecan, 
Mannedorf/Zürich, Switzerland).
To achieve cell survival (%), absorbance at 492 nm of a sample with cells grown in the 
presence of various concentrations of compounds tested was divided with absorbance of control 
sample (the absorbance of cells grown in nutrient medium only). The absorbance of blank probe 
was always subtracted from absorbance of a corresponding sample with cells. IC50 was defined 
as the concentration of the compound inhibiting the cell survival by 50%, compared to a vehicle-
treated control cells. All experimentally obtained IC50 data were means of three measurements.
2.3.2. Three-dimensional invasion assay. The effect of 1 to impair tumor cell invasion in a 3D 
model was evaluated using multi-cellular tumor spheroids (MCTS). MCTS were prepared 
according to the hanging drop method [32]. Twenty μL of HeLa cells suspension (150 cells per 
drop) were placed onto the lids of 90 mm tissue-culture dishes which were inverted over 10 mL 
of water. After 5 days, the formed aggregates were transferred to wells of Lab-Tek™ Chambered 
7Coverglass (Nalge Nunc International, Penfield, NY, USA) which had been coated with 70 μL of 
Matrigel (5 mg/mL) in SFM. Then, spheroids were covered with an additional 70 μL of Matrigel 
and after 20 min at 37 °C covered with 400 μL of the medium. Complex 1 (in concentration 
equal to IC50) was added to the Matrigel and the growth of spheroids was monitored for three 
days. As a control, only the medium was added to Matrigel. Images of tumor spheroids were 
obtained by using inverted microscope Olympus, Japan.
2.3.3. Antimicrobial activity. The antimicrobial activity of 1 and 2 was tested against Gram-
positive bacteria Staphylococcus aureus (ATCC 6538), Enterococcus faecalis (ATCC 29212) 
and Bacillus subtilis (ATCC 6633), Gram-negative bacteria Escherichia coli (ATCC 10536) and 
Klebsiella pneumoniae (ATCC 13883), and against Candida albicans (ATCC 10231) as yeast. 
Microorganisms were provided by the Institute of Immunology and Virology, Torlak, Belgrade. 
Each species was maintained on Mueller-Hinton agar (MHA), which was also used to confirm 
the absence of contamination and validity of the inocula. Before testing, each species was 
recovered by subculturing in Mueller-Hinton broth (MHB) aerobically for 24 h at 37 C. For 
Candida albicans Sabourad agar (SA) and Sabourad dextrose broth (SB) were used. Working 
concentrations (approximately 106 CFU/mL for bacteria, 105 CFU/mL for Candida albicans) 
used for antimicrobial activity assays were prepared by dilution of the culture in microbiological 
medium (for bacteria MHB, for Candida albicans SB). Compounds were dissolved in DMSO 
(2%) to prepare stock solutions sterilized by filtration through a 0.22-mm membrane filter 
(Sartorius AG, Germany) and further diluted with MHB to working solutions. DMSO was 
chosen as a non-toxic solvent [33, 34].
Broth microdilution method was employed to determine minimum inhibitory 
concentrations (MICs). The concentration of compounds ranged from 100 to 3.125 mM. Test 
bacterial culture (100 µL) in a MHB was added to the wells of a sterile 96-well microtiter plate 
(Sarstedt, Numbrecht, Germany) already containing 100 µL of twofold serially diluted 
compound in MHB. Also, 100 µL Candida albicans in SB was added to the wells 96-well 
microtiter plate already containing 100 µL of twofold serially diluted compounds in SB. The 
final volume in each well was 200 µL. The microplates were prepared in triplicate and incubated 
aerobically for 24 h at 37 °C. Wells with MHB were used as a sterility control, while negative 
controls were wells with tested compound in 100 µL of MHB, but without bacteria. Positive 
8controls were wells with 100 mL suspension of microorganisms in 100 µL of MHB (or SB for 
Candida albicans) and wells with bacterial suspension in a MHB with DMSO (or SB for 
Candida albicans), (to prove that DMSO had no inhibition effect on the microorganism’s 
growth).
To indicate cellular respiration, 2,3,5-triphenyltetrazolium chloride (TTC) (Aldrich 
Chemical Company Inc., Sigma-Aldrich, St. Louis, MO, USA) was added to the culture medium. 
The final concentration of TTC after inoculation was 0.05%. Viable microorganisms 
enzymatically reduced the white TTC to a pink TPF (1,3,5-triphenylformazan). The MIC was 
defined as the lowest concentration of the investigate compounds at which the microorganism 
does not demonstrate visible growth.
3. Results and discussion
3.1. Preparation
Complexes [Co4(pma)(tpmc)2](ClO4)4·6H2O (1) and [Cu2(pma)tpmc]∙8H2O (2) were prepared 
via the reaction of Co(ClO4)2∙6H2O and Cu(NO3)2∙3H2O with the ligand tpmc and previously 
neutralized pyromellitic acid in molar ratio 4:2:1.5 for 1 and 2:1:1.5 for 2. The complexes were 
obtained in good yield (~80%). The compounds were characterized by elemental analysis and 
spectroscopic techniques. Both complexes are microcrystalline solids, which are stable in air. 
Unfortunately, all attempts to grow single-crystals suitable for X-ray analyses of these 
complexes failed. For this reason, the structure of the complex is proposed based on 
spectroscopic and TG/DTA measurements and by comparison of the obtained data with some of 
the aromatic carboxylate complexes previously described. For some of them the structure was 
confirmed by X-ray analysis [18, 35].
3.2. LC-MS, UV-vis, reflectance, FTIR, EPR spectra and magnetic measurements
Electronic spectral data of 1 were recorded in CH3CN. In the visible region, there is a band at 
527 nm (ε = 264 M-1cm-1) and shoulder at 475 nm (ε = 219 M-1cm-1) and are due to 
4T1(F)4T1g (P) and 4T1(F)4A2g (F) transitions, respectively, typical for six-coordinate Co(II) 
complexes [36, 37], while the shape and position of the bands agree with those for high-spin 
Co(II) complexes with three unpaired electrons. Position of the band at 527 nm of 1 is very close 
to those of complexes Co(II)-tpmc with aromatic and α,ω-dicarboxylates, in the range 508-
9542 nm [17, 19]. This indicates the presence of the same chromofore (CoN4O2). Much higher 
ε value of 264 M-1cm-1 (1) than related dinuclear complexes (ε = 75-94 M-1cm-1 for aromatic and 
ε = 95-109 M-1cm-1 for aliphatic dicarboxylate macrocycle complexes) may be a consequence of 
the asymmetry and is consistent with the proposed formula for tetranuclear complex. In the UV 
region of the electronic spectrum of 1, several sharp unresolved bands are present in the range of 
252-310 nm (ε = 5439-5766 M-1cm-1) belonging to CT transitions. The Vis spectral data for 1 
and related complexes are shown in table 1.
For 2, the geometry is not easy to predict due to its solubility and scarce information. In 
reflectance spectrum, a band at 654 nm corresponds to d-d transitions in Cu(II) complexes. The 
absorption bands in the reflectance spectra of similar Cu(II) complexes are also in the range 621-
654 nm [35, 38, 39]. According to this result it can be assumed that 2 has the same chromophore 
(CuN4O) and five-coordinate Cu(II) as in the similar compounds.
In LC-MS spectrum of 1, there is no peak for molecular ion. The peaks and 
corresponding intensities from the fragmentation of the complex are given in table 2. The peak 
characteristic for the tpmc ligand also appears in the MS spectrum of 1 at 565,4 (7.83%) m/z, 
(C34H44N8+) [39, 40].
3.2.1. FTIR spectra. In the FTIR spectra of the complexes, some common characteristic bands 
are observed [41, 42]: a broad strong band at ~3400 cm-1 belongs to the stretching vibrations of 
crystal water, ν(H2O); a strong band at ~1610 cm-1 is typical for the skeletal vibration of pyridine 
from tpmc; the strongest band in the spectrum 1 at 1100 cm-1 belongs to the ν(ClO4-) and the 
sharp, medium intensity band at ~620 cm-1 to δ(ClO4-). FTIR spectra of the complexes and free 
ligands were used for the prediction of the composition as well as the proposition of the more 
favorable coordination modes. From shifting of the νasym(OCO) and νsym(OCO) bands in FTIR 
spectra of the complexes (table 1) in relation with those found in the spectrum of the pma ligand 
recorded for comparison (νasym(OCO-) = 1580 cm-1 and νsym(OCO-) = 1385 cm-1, Δν = 195 cm-1), 
it is obvious that OCO- groups are coordinated. Additional evidence for their coordination is the 
occurrence of the weak bands of ν(M-O) at ~420 cm-1, while bands at 480-470 cm-1 could be 
ascribed to ν(M-N) confirming the binding of macrocycle.
It is also known that the six-coordination is favorable for Co(II) ion [37, 42]. 
Significantly lower Δν value in 1 related to a pyromellitate ligand and νasym displacement 
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(table 1) towards lower values compared to the polycarboxylate indicates the combined chelate-
bridging manner of coordination [42]. Probably, oxygen atoms from one of the OCO- groups are 
bound to the same Co(II) ion, thus forming 4-membered rings (figure 1a) rather than enlarged 
(7-9 membered) rings (figure 1b and 1c). Similar coordination was proposed for aliphatic 
dicarboxylic anion in Co(II)-tpmc complexes [19].
In 2, bathochromic shift of νasym and νsym and the approximate Δν values of free ligand 
and complexes point to the bridging binding of the pyromellitate anions. The presence of four 
OCO- groups in the pyromellitate ligand provides opportunities for a variety of coordination 
modes [42, 43], but it is likely that only one carboxylate group participates in the coordination of 
Cu(II) ions, while the remaining groups either participate in hydrogen bonding with the water 
molecules in the crystal or even participate in the creation of the polymer structure. Monodentate 
coordination mode of two OCO- groups in bridging coordination can also be excluded because, 
in that case, unstable formed chelate rings would have 11 or more members (figure 1d). In that 
case, Δν is significantly higher then Δν of uncoordinated carboxylate anion [42, 43]. The 
engagement of more than two oxygen atoms from carboxylato ligands (each O is coordinated to 
one metal) in the coordination cannot be considered because it would be in contradiction with the 
diffusion-reflectance spectra and copper(II) coordination number of 5, as well as the particular 
chromophore and other methods applied. It is possible that one OCO- from pma4- ligand bridges 
Cu(II) atoms in 2 (figure 1e) and the rest of the O atoms are involved in the formation of 
H-bonds with water molecules. Other bridged coordination mode as well as the possible polymer 
structure of the complex cannot be excluded.
In table 1 the electronic and FTIR spectral data, the molar electrical conductivity (M) 
and the magnetic moments (eff) of 1 and 2 together with the corresponding data for some similar 
complexes from the literature are presented. It is evident that five-coordinate Cu(II) forms 
binuclear (benzoate, Hpht) or tetranuclear complexes (ipht) with the tpmc in a boat conformation 
(figure 1f) [18, 35]. Carboxylic group bridges two metallic centers within the same [Cu2tpmc]4+ 
unit. This type of coordination mode for one carboxylic group (μ-O,O') was confirmed 
previously by X-ray structure analyses of the complexes with bridging benzoate, isophthalate or 
succinate dianions [18, 35]. Complexes with dicarboxylate anions were tetranuclear. By 
comparing the spectroscopic properties of 2 with mono- and dicarboxylate complexes (table 1), it 
can be assumed that the same coordination pattern of carboxylate group, μ-O,O' is present. To 
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our knowledge, all complexes of Co(II) with dicarboxylate anions were binuclear with a 
coordination number of 6 for Co(II) [17, 19]. For the Co(II)-tpmc complexes, a combined 
chelate-bridging coordination of dicarboxylate was proposed. Since there were no single-crystal 
X-ray structural data for similar Co(II) complexes, on the basis of spectral characteristics, for 1 a 
coordination number of 6 is proposed.
Macrocyclic ligand tpmc is very flexible, adapting itself to different radii of the metal 
ions, as well as to the bridging ligand, thus causing diverse geometries and properties of the 
complexes. The greater tendency of Co(II), than Cu(II) under similar conditions, to form six-
coordinate species could explain some of these differences. Complex 1 is cationic tetranuclear 
with formula [Co4(pma)(tpmc)2](ClO4)4·6H2O in which the six coordination sites around the 
Co(II) are occupied by four N atoms from the macrocyclic ligand tpmc (two cyclam and two 
pyridyl N, figure 1f) and two oxygen atoms from pyromellitate anion. Complex 2 is neutral 
binuclear with formula [Cu2(pma)tpmc]∙8H2O. Each Cu(II) ion is five-coordinate with four N 
atoms (two from the cyclam and two from adjacent pyridyl groups, figure 1f) and O atom from 
the pyromellitate anion.
3.2.2. Magnetic properties. The magnetic moments of Co and Cu complexes are 4.96 BM/Co 
and 2.07 BM/Cu, respectively. Magnetic moment value at room temperature for 1 of 
4.96 BM/Co is higher than spin-only value of 3.87 BM/Co and in accord with the values 
experimentally found for high-spin Co(II) complexes with three unpaired electrons 4.7-
5.2 BM/Co [18, 19, 44]. Magnetic moment of 2.07 BM per Cu(II) at room temperature was in 
the range 1.75-2.20 BM/Cu found previously for similar five-coordinate Cu(II) complexes with 
one unpaired electron [18, 35, 39, 44].
EPR spectrum of powdered complex 2 is shown in figure 2. The EPR spectrum of 2 is 
typical for copper(II) in axially elongated tetragonal surrounding. This refers to the presence of a 
structure with a value of the effective spin S = 1/2 and dx2-y2 magnetic orbital occupied by one 
unpaired electron [45, 46]. For neutral complex [Cu2(pma)tpmc]∙8H2O (2), square planar 
arrangement four N atoms from tpmc in [Cu2tpmc]4+ with the O atoms from OCO- occupying 
definite positions along the tetragonal axis can be proposed [47]. The weak coordination of the O 
atoms imposes an elongated structure. It is intermediate between the free and the fully 
coordinated species [47]. The shape of spectrum is temperature independent.
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Similar EPR spectrum to 2 has been observed for related complex 
Cu2(Hpht)tpmc(ClO4)3·3H2O [38]. It suggests a possible square pyramidal geometry around 
the Cu(II) ion in 2, which would be in accord with the proposed CuN4O chromophore. EPR 
spectrum of 2 is similar to the EPR spectra of some Cu(II) complexes with μ-coordinated 
carboxylato anions, in which the X-ray analyses confirmed longer axial Cu(II)-O bond in relation 
to the others in the square-pyramidal plane [48].
3.3. Thermal analysis
Complex 2 undergoes a three-step decomposition, where the first endothermic step is the 
dehydration (figure 3). It starts at room temperature and ends at 130 °C. The weight loss 
corresponds to the evaporation of 15 molecules H2O (calculated: 22.3%; found: 23.1%). In the 
range 130-160 °C, the dehydrated compound is stable. The second stage in the range 160-200 °C 
is due to loss of the carboxylate groups from pyromellitate ligand (calculated: 14.5%; found: 
14.4%) and is accompanied by an exothermic heat effect. The shape of the TG curve and the 
high exothermic character of the decomposition refer to the burning of the sample with a final 
product at 400 °C which most probably belongs to CuO (calculated: 13.1%; found: 12.5%).
The previously discussed methods for the characterization of both complexes indicate 
that the analytical data of both complexes are compatible with the proposed composition.
3.4. Electrochemical properties
CV curves for 2 were recorded in DMSO in the range of potential -1.0 to 1.0 V with scan speed 
50, 100 and 200 mV/s (figure 4). No peak current was observed. The absence of peaks at about 
-0.34 V in the cathodic part from the reduction and around 0.00 V in the anodic part from the 
oxidation of copper on the electrodes confirmed the electrochemical stability of the studied 
complex under the given experimental conditions independent on the scan rate.
The electrochemical stability of 2 indicates that the dissolution of the complex in DMSO 
is not causing the dissociation of the complex. A similar electrochemical behavior was observed 
in most of the Cu(II)-tpmc complexes with bridged μ-coordinated aromatic/aliphatic 
mono/dicarboxylates [35, 38, 39]. Comparison of the UV-vis and diffusion reflectance spectra of 
those complexes shows that the dissolution causes a change in conformation of the macrocycle 
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rather than dissociation of the complex cation. Stability of 2 during the dissolution indicates that 
the antiproliferative activity is derived from the complex.
3.5. Antiproliferative and antibacterial activity
The cytotoxicity of 1 and 2 was tested with selected human cancer cell lines: cervix 
adenocarcinoma (HeLa), estrogen-receptor-positive human breast cancer (MCF-7), human 
myelogenous leukemia (K562) and the human Caucasian Burkitt’s lymphoma (Ramos) cells. 
The cytotoxic properties of target compounds are presented in table 3 and figures 5 and 6. Cell 
survival was determined by MTS test, after 48-h exposure to compounds (figures 5 and 6). Both 
compounds have promoted significant decreases in the metabolic activity of the HeLa, MCF-7, 
K562 and Ramos cell, which occurred in a dose-dependent fashion.
The use of metal complexes in the pharmaceutical industry has recently increased and as 
a result, novel metal-based complexes have started an interest as potential anticancer agents. 
Copper, which is an essential trace element in all living organisms, is important in maintaining 
the function of numerous proteins and enzymes. It has recently been demonstrated that Cu 
complexes may be used as tumor-specific proteasome inhibitors and apoptosis inducers by 
targeting the ubiquitin-proteasome pathway (UPP) [49]. The UPP plays an important role in cell 
growth and apoptosis and has been shown as a novel target for cancer therapy [50]. Also, Cu 
complexes have shown the potential to lead to apoptosis in PC-3 (human prostate cancer cells) 
and in MDA-MB-231 (human breast cancer cells) but not in nontumorigenic MCF-10A cells 
[51]. The cobalt complexes are of more limited medical use compared to copper complexes. 
Furthermore, cobalt complexes possess in vivo insulin-like properties [52], antifungal [53], anti-
oxidant activity [54] and antimicrobial activities [55, 56].
There are data indicating that cobalt-containing complexes are very interesting because 
they can be potent antitumor agents [57-59]. In addition, the antitumor active cobalt(II) 
complexes depend on the type and position of substituent in the aromatic rings [60].
The hanging drop method represents an attractive alternative for MCTS production 
because it is mild, can be applied to a wide variety of cell lines, and can produce spheroids of a 
homogeneous size without the need for sieving or manual selection. The method has applications 
for basic studies of physiology and metabolism, tumor biology, toxicology, cellular organization, 
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and development of bioartificial tissue. In figure 7, it can be noticed that complex 
[Co4(pma)(tpmc)2](ClO4)4·6H2O diminished migration of HeLa cells [32].
Compounds 1 and 2 were tested for antimicrobial activity against three Gram-positive 
and two Gram-negative bacterial strains, as well as against one strain of yeast Candida albicans.
The activity was observed for 1 against Staphylococcus aureus (MIC = 25 mM), Bacillus 
subtilis (MIC = 25 mM) and Klebsiella pneumoniae (MIC = 25 mM), whereas the strains of 
Enterococcus faecalis, Escherichia coli and Candida albicans were not susceptible. 
Experimental results obtained from the study of antimicrobial activity demonstrate that 1 
displays bacteriostatic activity in the concentration of 25 mM (53 μg/mL).
Complex 2 did not express activity against tested microbial strains (table 4). The data 
from the literature suggest that MIC is influenced by the nature of the metal ion as well as by the 
presence of an anion in the coordination sphere [61]. The data so far show that the antibacterial 
activity of the complex of tetraazamacrocyclic metal complexes can be interpreted in terms of 
the theory of chelation. Chelation/coordination reduces the polarity of the metal. The chelation 
process increases the lipophilic nature of the central metal, favoring the path through the lipid 
layer of the membrane, which transmits the metal complex to the bacterial membrane more 
effectively, by blocking the locations of metal binding to microorganisms. This prevents protein 
synthesis and growth of microorganisms [62-65].
4. Conclusion
In this article we reported the synthesis, spectroscopic, electrochemical and thermal properties of 
new Co(II) and Cu(II) mixed-ligand complexes with octaazamacrocyclic ligand tpmc and 
polycarboxylate-pyromellitic acid. The Co(II) complex is tetranuclear in which the six 
coordination sites around the Co(II) are occupied by four nitrogen atoms from the macrocyclic 
ligand tpmc (two cyclam and two pyridyl N) and two oxygen atoms from piromellitate anion. All 
oxygen atoms are engaged in coordination and probably one carboxylate group connecting the 
Co(II) ions as bidentate The complex Cu(II) is neutral binuclear with five-coordinate Cu(II) ions, 
four N atoms (two cyclam and two pyridyl N) and O atom from the pyromellitate anion. One 
carboxylate group is bridging two Cu(II) ions inside tpmc unit. Cobalt(II) complex showed 
antibacterial activity against bacteria and cytotoxic activity against four human cancer cell lines. 
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These results indicate that the type of metal ion in the complex can affect their composition, 
properties, anti-proliferative and antimicrobial activity.
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Figure captions
Figure 1. Selected coordination modes of pma ligand (a-e) and exo coordination of M=Co(II), 
Cu(II) in binuclear tpmc unit where tpmc adopted boat conformation (f).
Figure 2. EPR spectrum at room temperature for 2 (similar spectrum is observed at LN2 
temperature).
Figure 3. Simultaneous TG-DTA of 2.
Figure 4. Cyclic voltammogram of 2 in DMSO (with scan speed of 100 mV/s).
Figure 5. Cells were incubated with various concentrations of 1 and 2. After 48 h of incubation, 
MTS reagent was added. Obtained data show the optical density of cell cultures. Each 
experiment was repeated three times and the results were presented as the mean value of ± SD.
Figure 6. Dose-response curves for the cytotoxicity of 1 and 2 toward HeLa, MCF-7, K562 and 
Ramos cells. Percentage of viable cells was plotted against various concentrations of investigated 
compounds.
Figure 7. [Co4(pma)(tpmc)2](ClO4)4·6H2O (1) to impair invasion of HeLa cells in a 3D in vitro 
model of tumor invasion. (A) MCTS were implanted in Matrigel and covered with growth 
medium. (B) MCTS were implanted in Matrigel and covered with growth medium with 1. 
Representative images of HeLa MCTS were obtained at day three after treatment with 1.
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Table 1. Electronic and FTIR spectral data, molar electrical conductivity (ΛM) and magnetic moments 
(eff) of 1 and 2 along with some similar compound from the literature [17, 18, 35, 38].
FTIR
Complexes
max ()
nm 
(M-1 
cm-1)
M S 
cm2 mol-
1C
(electrolyt
e type)
eff 
[BM/M(II
) νasym(OCO)
νsym(OC
O) Δν
[Co2(C6H5COO)2tpmc](ClO4)2∙3H2O
*
516 
(75), 
sh 
479 
(66)a-
b
143 
(1:2)
4.81 1580 1413
16
7
[Co2(pht)tpmc](ClO4)2∙2H2O*
523 
(86), 
sh 
487 
(74)a-
b
172 
(1:2)
4.74 1544 1423
12
1
[Co2(ipht)tpmc](ClO4)2∙4H2O*
508 
(94), 
sh 
485 
(89)a-
b
116 
(1:2)
5.01 1538 1425
11
3
[Co4(pma)(tpmc)2](ClO4)4∙6H2O (1) 
527 
(264), 
sh 
475 
(219)a
-b
636 
(1:4)
4.96 1546 1400
14
6
Cu2(C6H5COO)tpmc(ClO4)3∙CH3O
H* 
671 
(365)a
310 
(between 
1.88 1555 1382 
17
3
25
, 621b 1:2 i 1:3)
Cu2(Hpht)tpmc(ClO4)3·3H2O* 
658 
(335)a
, 643b
435 
(≈1:3)
1.74
1713, 
1576, 
1565 
1391, 
1357, 
1298
19
6
[Cu4(ipht)(tpmc)2](ClO4)6∙NaClO4∙2
H2O* 
676 
(652)a
, 654b
800 
(1:6)
1.76
1573, 
1560
1387 
18
0
[Cu2(pma)tpmc]∙8H2O (2)
-a, 
654b
- 2.07 1572 1381
19
1
a, c in CH3CN solution, b reflectance spectra; * data from literature [17, 18, 35, 38], H2pht = phthalic acid, H2ipht = 
isophthalic acid, H4pma = piromellitic acid
Table 2. The fragmentation ions of 1 in LC-MS spectrum (positive ion mode).
Fragmentation ions m/z a Relative intensity (%)
[Co2(C6H2(COOH)4)(C34H44N8)](ClO4)44+ 333.2 (333.5) 16.27
[Co2(C6H2(COO)2)(COOH)2)(C34H44N8)](ClO4)42+ 667.9 (667.3) 7.83
[Co2(C6H2(COOH)4) (C34H44N8)](ClO4)26+ 189.1 (189.0) 3.01
[Co2(C6H2(COO)(COOH)3)(C34H44N8)](ClO4)25+ 227.0 (226.8) 7.23
[Co2(C6H2(COO)2)(COOH)2)(C34H44N8)](ClO4)24+ 284.2 (283.3) 39.16
[Co2(C6H2(COO)4)(C34H44N8)](ClO4)22+ 565.7 (565.5) 3.01
C34H44N8+ 565.4 (564.8) 7.83
a Calculated values are given in parentheses
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Table 3. Concentrations of 1, 2 and ligands that induced 50% decrease in cell survival (IC50).
IC50±SD (M)
Compound
HeLa MCF-7 K 562 Ramos
[Co4(pma)(tpmc)2](ClO4)4·6H2O 44.66±2.39 71.79±2.94 152.40±2.28 81.66±0.79
[Cu2(pma)tpmc]∙8H2O 165.19±1.37 163.20±6.90 192.05±2.09 140.88±3.51
tpmc >200 >200 >200 >200
pma >200 >200 >200 >200
cisplatin 10.9±3.5 4.9±1.7 7.9±2.5 5.9±3.8
All data are results from three independent experiments, each carried out in triplicate. The results are 
presented as mean IC50 ± standard deviation, µM.
Table 4. Antimicrobial activity of 1 and 2 and expressed as MIC (mM and g/mL), determined by the 
broth microdilution methods.
Microbial strain
Co4(pma)(tpmc)2](ClO4)4·6H2O
mM (µg/mL)
[Cu2(pma)tpmc]∙8H2O
mM (µg/mL)
Ampicillin
µg/mL
Nystatin
µg/mL
S. aureus 25 (53) > 100 (>119) 1 nt
B. subtilis 25 (53) > 100 (>119) 8 nt
E. faecalis > 100 (>212) > 100 (>119) 8 nt
E. coli > 100 (>212) > 100 (>119) 2 nt
K. pneumoniae 25 (53) > 100 (>119) 2 nt
C. albicans > 100 (>212) > 100 (>119) nt 4
nt = not tested
